FIELD: chemistry.
SUBSTANCE: invention refers to cyanoguanidine derivatives of the general formula I in which A, A, X1, X2, X3, Y1, Y2, Y3, R1, R2, R5, R6 and n have the values indicated in the formula of the invention. The invention also refers to the pharmaceutical composition which has antiproliferative activity on the basis of the compound of the formula I, and application of these compounds for medicinal preparation aimed at treatment and alleviation of proliferative disease and conditions.
EFFECT: new compounds can be useful at proliferative disease treatment.
25 cl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
CYANOGUANIDINE PRODRUGS | 2001 |
|
RU2312858C2 |
DERIVATIVES OF PYRIDYLCYANOGUANIDINES AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2002 |
|
RU2292344C2 |
METHOD FOR TREATMENT OF ALLERGY BY USING SUBSTITUTED PYRAZOLES | 2001 |
|
RU2259202C2 |
SUBSTITUTED 3-PYRIDYLMETHYLAMINES AND FOCUSED LIBRARY | 2003 |
|
RU2228930C1 |
CONDENSED HETEROCYCLIC COMPOUND | 2005 |
|
RU2389731C2 |
DERIVATIVES OF 2-SUBSTITUTED PHENYL-5,7-DIHYDROCARBYL-3,7-DIHYDROPYRROLO[2,3-d]PYRIMIDIN-4-ONES, THEIR PREPARING AND PHARMACEUTICAL USING | 2004 |
|
RU2323220C2 |
AGENT WHICH PREVENTS PREMATURE OVULATION | 2006 |
|
RU2419435C2 |
AMIDINONAPHTYL DERIVATIVES AND PHARMACEUTICAL COMPOSITION | 1995 |
|
RU2154633C2 |
NOVEL COMPOUNDS, ISOMERS THEREOF OR PHARMACUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONISTS AND PHARMACEUTICAL COMPOSITION CONTAINING SAID COMPOUNDS | 2007 |
|
RU2448108C2 |
MALONONITRILE COMPOUND AS PESTICIDE | 2005 |
|
RU2347779C2 |
Authors
Dates
2008-06-20—Published
2003-05-15—Filed